With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.4199-88-6,5-Nitro-1,10-phenanthroline,as a common compound, the synthetic route is as follows.
General procedure: [(eta3-C3H5)Mo(CO)2(NCMe)2Cl] (1; 200 mg; 0.64 mmol) was dissolved in CH2Cl2 (50 mL) and treated with 5-nitro-1,10-phenanthroline (145 mg, 0.64 mmol). The solution was stirred for 30 min at room temperature. After that, the solvent was vacuum evaporated. The crude product was washed with ether and recrystallized from the mixture CH2Cl2/ether and vacuum dried. Yield: 270 mg (93%, 0.60 mmol). Anal. Calcd for C17H12ClMoN3O4: C, 45.00; H, 2.67; N, 9.26. Found: C, 45.12; H, 2.70; N, 9.23. 1H NMR (d6-acetone, 400 MHz, 25 C, delta ppm): 9.45-9.40 (m, 2H,C12H7N2), 9.24 (d, J(1H,1H) = 8.2 Hz, 1H, C12H7N2), 9.16 (s, 1H, C12H7N2), 9.06 (d, J(1H,1H) = 8.2 Hz, 1H, C12H7N2), 8.19 (s, 1H, C12H7N2), 3.35 (m, 1H, C3H5), 3.29 (d, J(1H,1H) = 6.2 Hz, 2H, C3H5), 1.37 (d, J,(1H,1H) = 8.7 Hz, 2H, C3H5). FTIR (ATR, cm-1): 1930 vs [nua(CO)], 1842 vs [nus(CO)], 1540 [nus(NO)], 1535 [nua(NO)].
As the paragraph descriping shows that 4199-88-6 is playing an increasingly important role.
Reference£º
Article; Honzi?ek, Jan; Vinklarek, Jaromir; Pad?lkova, Zde?ka; ?ebestova, Lucie; Foltanova, Karolina; ?eza?ova, Martina; Journal of Organometallic Chemistry; vol. 716; (2012); p. 258 – 268;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI